MEDP Medpace Holdings Inc
- Stocks
- Healthcare
- NASDAQ: MEDP
Price (delayed)
$598.81
Market cap
$16.87B
P/E Ratio
40.85
Dividend/share
N/A
EPS
$14.66
Enterprise value
$16.7B
Relative Growth:
Rel. Growth:
98
Relative Strength:
Rel. Strength:
91
Relative Valuation:
Rel. Valuation:
29
Relative Profitability:
Rel. Profitability:
53
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace's mission is to accelerate
Highlights
The EPS is up by 24% YoY and by 6% QoQ
MEDP's gross profit is up by 19% year-on-year and by 4% since the previous quarter
Medpace Holdings's equity has soared by 70% from the previous quarter but it has plunged by 67% YoY
Medpace Holdings's quick ratio has increased by 46% QoQ but it has decreased by 45% YoY
The P/E is 55% higher than the last 4 quarters average of 26.4 and 33% higher than the 5-year quarterly average of 30.7
Key stats
What are the main financial stats of MEDP
Market
Valuations
Earnings
Shares outstanding
28.17M
Market cap
$16.87B
Enterprise value
$16.7B
Price to earnings (P/E)
40.85
Price to book (P/B)
57.29
Price to sales (P/S)
7.14
PEG
1.71
EV/EBIT
32.65
EV/EBITDA
29.65
EV/Sales
7.08
Revenue
$2.36B
Gross profit
$733.62M
Operating income
$507.04M
Net income
$433.01M
EBIT
$511.54M
EBITDA
$563.19M
Free cash flow
$676.77M
Per share
Balance sheet
Liquidity
EPS
$14.66
EPS diluted
$14.3
Free cash flow per share
$24.05
Book value per share
$10.45
Revenue per share
$83.82
TBVPS
$37.57
Total assets
$1.75B
Total liabilities
$1.46B
Debt
$119.07M
Equity
$293.64M
Working capital
-$546.63M
Debt to equity
0.41
Current ratio
0.57
Quick ratio
0.51
Net debt/EBITDA
-0.3
Margins
Efficiency
Dividend
EBITDA margin
23.9%
Gross margin
31.1%
Net margin
18.4%
Operating margin
21.5%
Return on assets
23.7%
Return on equity
91.9%
Return on invested capital
N/A
Return on capital employed
109%
Return on sales
21.7%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
MEDP stock price
How has the Medpace Holdings stock price performed over time
Intraday
0.72%
1 week
2.44%
1 month
12.45%
1 year
82.43%
YTD
80.24%
QTD
16.46%
Financial performance
How have Medpace Holdings's revenue and profit performed over time
Revenue
$2.36B
Gross profit
$733.62M
Operating income
$507.04M
Net income
$433.01M
Gross margin
31.1%
Net margin
18.4%
The operating income has increased by 24% year-on-year and by 6% since the previous quarter
MEDP's gross profit is up by 19% year-on-year and by 4% since the previous quarter
The net income has increased by 18% YoY and by 3.5% from the previous quarter
MEDP's revenue is up by 14% year-on-year and by 6% since the previous quarter
Price vs fundamentals
How does MEDP's price correlate with its fundamentals
Growth
What is Medpace Holdings's growth rate over time
Valuation
What is Medpace Holdings stock price valuation
P/E
40.85
P/B
57.29
P/S
7.14
EV/EBIT
32.65
EV/EBITDA
29.65
EV/Sales
7.08
The P/E is 55% higher than the last 4 quarters average of 26.4 and 33% higher than the 5-year quarterly average of 30.7
The EPS is up by 24% YoY and by 6% QoQ
MEDP's price to book (P/B) is 77% higher than its last 4 quarters average of 32.4
Medpace Holdings's equity has soared by 70% from the previous quarter but it has plunged by 67% YoY
MEDP's price to sales (P/S) is 49% more than its last 4 quarters average of 4.8 and 40% more than its 5-year quarterly average of 5.1
MEDP's revenue is up by 14% year-on-year and by 6% since the previous quarter
Efficiency
How efficient is Medpace Holdings business performance
The company's return on equity has surged by 81% YoY and by 36% QoQ
Medpace Holdings's return on assets has increased by 21% YoY and by 8% QoQ
The ROS is up by 4.3% YoY
Dividends
What is MEDP's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for MEDP.
Financial health
How did Medpace Holdings financials performed over time
The company's total assets is 20% higher than its total liabilities
Medpace Holdings's quick ratio has increased by 46% QoQ but it has decreased by 45% YoY
Medpace Holdings's current ratio has decreased by 42% YoY but it has increased by 33% QoQ
The debt is 59% smaller than the equity
MEDP's debt to equity has surged by 173% year-on-year but it is down by 43% since the previous quarter
Medpace Holdings's equity has soared by 70% from the previous quarter but it has plunged by 67% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.